VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

Date Died:

ID: 1655116
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Passed away after being vaccinated; This is a spontaneous report from a Pfizer sponsored program from a Non-contactable consumer (reporter's cousin). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter stated his cousin pass away after being vaccinated. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Passed away after being vaccinated

Other Meds:

Current Illness:

Date Died:

ID: 1655117
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: Covid; Test Result: Positive

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Died due to the fact he received the Covid shot; Tested Positive for Covid after Vaccine; Tested Positive for Covid after Vaccine; This is a spontaneous report from a contactable consumer (patient's friend). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The consumer stated she knew that a friend (the patient) died due to the fact he received the Covid shot. The consumer stated all of the patient's body and organs were spiked with proteins, and they were elevated from Covid. The patient was tested Positive for Covid after Vaccine on an unspecified date. The patient died on an unspecified date. It was not reported if an autopsy was performed. The outcome of the event tested Positive for Covid was unknown. The lot number for [bnt162b2], was not provided and will be requested during follow up.; Reported Cause(s) of Death: died due to the fact he received the Covid shot

Other Meds:

Current Illness:

Date Died: 02/08/2021

ID: 1655118
Sex: F
Age:
State: FL

Vax Date: 02/05/2021
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Hypoplastic left heart syndrome; This is a spontaneous report from a contactable consumer (patient's father). A 33-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 05Feb2021 (reported as in the afternoon, after 1400) (Batch/Lot Number: EN5318) (at the age of 33-years-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included heart issue with her heart from an unknown date, several heart surgeries from an unknown date. There were no additional vaccines administered on same date of the Pfizer Suspect. Prior Vaccinations (within 4 weeks) was none. There was no family medical history relevant to AE. Concomitant medication included ASPIRIN [acetylsalicylic acid] tablet taken for an unspecified indication, start and stop date were not reported. The consumer stated he did not keep close contact on all her medications since she was not living with her parents. The patient experienced hypoplastic left heart syndrome on an unspecified date and died for it on 08Feb2021. The consumer was reporting that his daughter passed away after she got the first Pfizer covid shot. She passed away in February. She got her shot on a Friday and passed away Monday evening. She did have a heart issue with her heart. At the time she had been through several heart surgeries and they did not realize the covid vaccine had issues for cardiac patients. The vaccine was recommended by her doctors. He reported she had hypoplastic left heart syndrome and that was the cause of death. She died on 08Feb2021. She died in her sleep, between 12:30am and 7:30am on 08Feb2021. She did not have an autopsy done at the time. He reported she had just got the shot and he was not sure if she died from natural causes or from the shot. In his heart he felt like she had been cut up enough and did not have an autopsy done. If he knew then the information that he knew now, then he would have had an autopsy done. She received vaccine basis that of her doctor's recommendation and her mother's panic about her covid and dyeing an ugly death, she had two cardiovascular surgeons that both recommended to get the covid vaccine. There was no Emergency Room visit and no physician office visit. The patient died on 08Feb2021. An autopsy was not performed. The outcome of the event hypoplastic left heart syndrome was fatal.; Reported Cause(s) of Death: Hypoplastic left heart syndrome

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1655119
Sex: M
Age:
State:

Vax Date: 08/02/2021
Onset Date: 08/01/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: pre existing condition; peripheral neuropathy; and it has got a little worse; neuropathy was aggravated; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program COVAX US support. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: not reported), via an unspecified route of administration on 02Aug2021 as dose 1, single for COVID-19 immunization. Medical history included peripheral neuropathy (Now he has a pre-existing condition which is Peripheral Neuropathy (Medical Condition)). Concomitant medications were not reported. On an unspecified date in Aug2021, the patient experienced pre-existing condition; peripheral neuropathy; and it has got a little worse; neuropathy was aggravated. The outcome of the event was unknown. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.

Other Meds:

Current Illness:

Date Died:

ID: 1655120
Sex: M
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: had a heart attack and died; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient's wife). A male patient of unknown age received first and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), both on unknown date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient was fully vaccinated with the Pfizer Covid 19 vaccine, had a heart attack after both vaccine. The patient died due to heart attack. It was unknown if autopsy was done. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: had a heart attack and died.

Other Meds:

Current Illness:

ID: 1655121
Sex: M
Age:
State: MI

Vax Date: 05/18/2021
Onset Date: 08/18/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210818; Test Name: tested positive; Test Result: Positive

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: tested positive after being fully vaccinated; tested positive after being fully vaccinated; This is a spontaneous report from contactable consumer (Patient wife). A 44-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration in Arm Right on 27Apr2021 (Batch/Lot Number: EW0167, NDC number and Expiry Date: Unknown) as dose 1, single (Age at Time of Vaccination: 44-years-old) and dose 2 via an unspecified route of administration in Arm Right on 18May2021 (late morning) (Batch/Lot Number: EW0178, NDC number and Expiry Date: Unknown) as dose 2, single (Age at Time of Vaccination: 44-years-old) both taken for COVID-19 immunisation. Medical history included crohn's disease (Diagnosed Spring 2018) from 2018 and ongoing. Concomitant medications included infliximab dyyb (INFLECTRA [INFLIXIMAB DYYB]) taken for crohn's disease from an unspecified start date and ongoing; azathioprine taken for crohns disease from an unspecified start date and ongoing. The patient previously took remicade on an unknown date. The patient underwent lab test and procedure which included tested positive (SARS-CoV-2 test): Positive on 18Aug2021. There was no history of all previous immunization with the Pfizer vaccine considered as suspect, there were no additional vaccines administered on same date of the Pfizer suspect, there were no prior vaccinations (within 4 weeks) the patient took. The vaccine was administered at Military facility. The patient did not have adverse event following prior vaccinations. The reporter stated that her husband was fully vaccinated, He had the second dose on 18May2021 and since tested positive for the virus (18Aug2021). They have 4 other friends who are fully vaccinated who tested positive. The reporter would give them the number to call and added that the phone tree was horrific to try to get through on. The patient did not go to Emergency Room and Physician Office. The events were considered as serious (Medically Significant). The outcome for events was unknown. Follow-up attempts are completed. No further information was expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101095815 same reporter/drug/AE, different patients.;US-PFIZER INC-202101095813 same reporter/drug/AE, different patients.;US-PFIZER INC-202101095814 same reporter/drug/AE, different patients.;US-PFIZER INC-202101095816 same reporter/drug/AE, different patients.

Other Meds: INFLECTRA [INFLIXIMAB DYYB]; AZATHIOPRINE

Current Illness: Crohn's disease (Diagnosed Spring 2018.)

ID: 1655122
Sex: M
Age:
State: MI

Vax Date: 05/18/2021
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Tested positive; Test Result: Positive

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: who are fully vaccinated who tested positive; who are fully vaccinated who tested positive; This is a spontaneous report from a contactable consumer or other non hcp. A 44-years-old male patient received bnt162b2 (BNT162B2, formulation: solution for injection, Batch/Lot Number: EW0167), via an unspecified route of administration, administered in Arm Right on 27Apr2021 (at the age of 44-years-old) as DOSE 1, SINGLE and dose 2 bnt162b2 (BNT162B2, formulation: solution for injection, Batch/Lot Number: EW0178), via an unspecified route of administration, administered in Arm Right on 18May2021 (at the age of 44-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included crohn's disease from 2018 and ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications included Inflectra 400mg infusion every 8 weeks for crohn's disease and Azathioprine 50mg daily for crohn's disease. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient was tested positive for Covid 19. Reported as: who are fully vaccinated who tested positive. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: positive. The outcome of the events was unknown. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101095688 same reporter/drug/AE, different patients.

Other Meds: INFLECTRA [INFLIXIMAB]; AZATHIOPRINE

Current Illness: Crohns disease aggravated

ID: 1655123
Sex: U
Age:
State: MI

Vax Date: 05/18/2021
Onset Date: 08/18/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: Tested positive after being fully vaccinated; Test Result: Positive

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: who are fully vaccinated who tested positive; who are fully vaccinated who tested positive; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 18May2021 (Batch/Lot Number: EW0178) as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 via an unspecified route of administration, administered in Arm Right on 27Apr2021 (Batch/Lot Number: EW0167) as for covid-19 immunization. Any other vaccinations within four weeks prior to the first administration date of the suspect vaccine reported as none. AEs following prior vaccinations reported as none. On 18Aug2021, the patient experienced who are fully vaccinated who tested positive (medically significant). Reporter states her husband is fully vaccinated. He had the second dose since tested positive for the virus. They have 4 other friends who are fully vaccinated who tested positive. The patient did not visit emergency room or physician office for AEs. The patient underwent lab tests and procedures which included sars-cov-2 test as positive on an unspecified date in 2021. The outcome of events was not recovered. Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101095688 same reporter/drug/AE, different patients.

Other Meds:

Current Illness:

ID: 1655124
Sex: U
Age:
State: MI

Vax Date: 05/18/2021
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: COVID-19; Test Result: Positive

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: who are fully vaccinated who tested positive; who are fully vaccinated who tested positive; This is a spontaneous report from a contactable consumer or other non hcp. A patient of unspecified age and gender received first dose of first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EW0167), via an unspecified route of administration, administered in Arm Right on 27Apr2021 as single dose and patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EW0178) via an unspecified route of administration, administered in Arm Right on 18May2021 ,as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient taking COVID Vaccine for COVID prevention. Prior Vaccinations within four weeks prior to the first administration date of the suspect vaccine was none. It was reported that relevant test was none.It was reported that Investigation Assessment was No. Adverse event following prior vaccinations was None. It was reported that Additional Vaccines Administered on Same Date of the Pfizer Suspect was None. It was reported that History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations were not available) was None. Time the Vaccination Given was late morning. The patient experienced who are fully vaccinated who tested positive on 2021. It was reported that Emergency Room and Physician Office visit was no. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 2021. The outcome of the events was unknown. Follow-Up (25Aug2021): Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101095688 same reporter/drug/AE, different patients.

Other Meds:

Current Illness:

ID: 1655125
Sex: M
Age:
State: LA

Vax Date: 02/11/2021
Onset Date: 03/01/2021
Rec V Date: 08/30/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202103; Test Name: blood test; Result Unstructured Data: Test Result: Unknown results; Test Date: 202103; Test Name: brain scan; Result Unstructured Data: Test Result: Unknown results; Test Date: 202103; Test Name: urine test; Result Unstructured Data: Test Result: Unknown results.

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Having memory issues after taking the Pfizer vaccination; Or if the vaccination may have triggered something in his brain to react like Dementia; This is a spontaneous report from a contactable consumer received via Pfizer sponsored program. A 58-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on 21Jan2021 as single dose and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on 11Feb2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The consumer wanted to confirm, could the Pfizer vaccination cause some memory loss, her husband (patient) was having memory issues after taking the Pfizer vaccination and she was wondering if that was a possible rare side effect that may get better with time or if the vaccination may have triggered something in his brain to react like Dementia. The patient further stated that in early March the patient started having memory problems and was admitted to the hospital and he received both, the different blood test and urine test and brain scan and so far, he was being diagnosed with probable dementia. The patient was a 58 years old male and all this happened in early March after receiving the first two dose of the vaccine in January and February. The patient underwent lab tests and procedures which included blood test, scan brain and urine analysis, all unknown results on an unknown date in Mar2021. The clinical outcome for events was unknown. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1655126
Sex: F
Age:
State: IL

Vax Date: 03/20/2021
Onset Date: 03/25/2021
Rec V Date: 08/30/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210313; Test Name: Blood tests; Result Unstructured Data: Test Result:Many; Test Date: 20210314; Test Name: CT Scans; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210314; Test Name: INR; Result Unstructured Data: Test Result:Ongoing; Test Date: 20210315; Test Name: MRI; Result Unstructured Data: Test Result:Strokes-eye and brain; Test Date: 20210511; Test Name: Covid test; Test Result: Negative ; Test Date: 20210314; Test Name: Ultrasound; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: short of breath; This is a spontaneous report from a contactable consumer. A 73-year-old female patient received second dose of bnt162b2 (BNT162B2) at the age of 73-year-old, dose 2 via an unspecified route of administration, administered in Arm Right on 20Mar2021 11:00 (Batch/Lot Number: ER2613) as dose 2, single for covid-19 immunisation. Medical history included atrial fibrillation (A Fib) from 2019 and ongoing (Pertinent details: Watchman procedure 13May2021), ongoing hypertension (High BP), diabetes from 2018 and ongoing , breast cancer from 1995 to an unknown date (Pertinent details: Lumpectomy 1995 mastectomy 2019), Lumpectomy from 1995 to an unknown date, mastectomy from 2019 to an unknown date, Left eye blindness from an unknown date and unknown if ongoing (Pertinent details: Many tests), cerebrovascular accident from 12Mar2021 to an unknown date, ongoing allergies, stroke from 12Mar202. Family medical history was none. Concomitant medications included rivaroxaban (XARELTO) Pill taken for atrial fibrillation (A Fib) from an unspecified start date to 13Mar2021; sitagliptin phosphate (JANUVIA) Pill taken for diabetes mellitus ongoing; metoprolol (METOPROLOL) taken for atrial fibrillation (A Fib) ongoing; loratadine (CLARINET) Pill taken for hypersensitivity (Allergies) ongoing. The patient previously took first dose of bnt162b2 (Batch/Lot number: EN6203 ) on 27Feb2021 10:00 AM in Right arm for covid-19 immunization and experienced Eye stroke on 12Mar2021 10PM with Seriousness criteria: Hospitalization/prolongation of hospitalization, Persistent/Significant disability/Incapacity and hospitalized for 4 Days, required visit to Emergency room and Physician office, outcome of not recovered, treatment received included many. The patient experienced short of breath on 25Mar2021 04:00 AM with outcome of recovering, required visit to Emergency room and treatment received included Heart meds. The patient was hospitalized for short of breath for 3 days. Seriousness criteria of the events was hospitalization, life threatening. The patient underwent lab tests and procedures which included blood test: many on 13Mar2021, computerised tomogram (CT Scans) : unknown results on 14Mar2021, international normalised ratio (INR ): ongoing on 14Mar2021, magnetic resonance imaging(MRI): strokes-eye and brain on 15Mar2021, sars-cov-2 test (Covid test): negative on 11May2021, ultrasound scan: unknown results on 14Mar2021. Vaccination facility type was hospital. Prior vaccinations was none. No Autopsy information. Follow-up attempts are completed. No further information is expected.

Other Meds: XARELTO; JANUVIA; METOPROLOL; CLARINET

Current Illness: AFib (Pertinent details: Watchman procedure 13May2021); Allergy; Blood pressure high; Diabetes

ID: 1655127
Sex: U
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: had the breakthrough infections had had two doses of the Pfizer vaccine; had the breakthrough infections had had two doses of the Pfizer vaccine; This is a spontaneous report from a contactable physician reporting same events under the same suspect product for 10 total number patients. This is one of 10 reports. A patient of unspecified age and gender received two doses of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported ten patients had breakthrough infections. Local pharmacies in their area giving booster dose and the patients that had had the breakthrough infections had had two doses of the Pfizer vaccine on an unspecified date with outcome of unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported COVID infections based on the known safety profile.,Linked Report(s) : US-PFIZER INC-202101058062 same reporter/SD/AE, different patient

Other Meds:

Current Illness:

ID: 1655128
Sex: U
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: had the breakthrough infections had had two doses of the Pfizer vaccine; had the breakthrough infections had had two doses of the Pfizer vaccine; This is a spontaneous report from a contactable physician reporting same events under the same suspect product for 10 total number patients. This is one of 10 reports. A patient of unspecified age and gender received two doses of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported ten patients had breakthrough infections. Local pharmacies in their area giving booster dose and the patients that had had the breakthrough infections had had two doses of the Pfizer vaccine on an unspecified date with outcome of unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported COVID infections based on the known safety profile.,Linked Report(s) : US-PFIZER INC-202101058062 same reporter/SD/AE, different patient

Other Meds:

Current Illness:

ID: 1655129
Sex: U
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: had the breakthrough infections had had two doses of the Pfizer vaccine; had the breakthrough infections had had two doses of the Pfizer vaccine; This is a spontaneous report from a contactable physician reporting same events under the same suspect product for 10 total number patients. This is one of 10 reports. A patient of unspecified age and gender received two doses of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported ten patients had breakthrough infections. Local pharmacies in their area giving booster dose and the patients that had had the breakthrough infections had had two doses of the Pfizer vaccine on an unspecified date with outcome of unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported COVID infections based on the known safety profile.,Linked Report(s) : US-PFIZER INC-202101058062 same reporter/SD/AE, different patient

Other Meds:

Current Illness:

ID: 1655130
Sex: U
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: had the breakthrough infections had had two doses of the Pfizer vaccine; had the breakthrough infections had had two doses of the Pfizer vaccine; This is a spontaneous report from a contactable physician reporting same events under the same suspect product for 10 total number patients. This is one of 10 reports. A patient of unspecified age and gender received two doses of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported ten patients had breakthrough infections. Local pharmacies in their area giving booster dose and the patients that had had the breakthrough infections had had two doses of the Pfizer vaccine on an unspecified date with outcome of unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported COVID infections based on the known safety profile.,Linked Report(s) : US-PFIZER INC-202101058062 same reporter/SD/AE, different patient

Other Meds:

Current Illness:

ID: 1655131
Sex: U
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: had the breakthrough infections had had two doses of the Pfizer vaccine; had the breakthrough infections had had two doses of the Pfizer vaccine; This is a spontaneous report from a contactable physician reporting same events under the same suspect product for 10 total number patients. This is one of 10 reports. A patient of unspecified age and gender received two doses of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported ten patients had breakthrough infections. Local pharmacies in their area giving booster dose and the patients that had had the breakthrough infections had had two doses of the Pfizer vaccine on an unspecified date with outcome of unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported COVID infections based on the known safety profile.,Linked Report(s) : US-PFIZER INC-202101058062 same reporter/SD/AE, different patient

Other Meds:

Current Illness:

ID: 1655132
Sex: U
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: had the breakthrough infections had had two doses of the Pfizer vaccine; had the breakthrough infections had had two doses of the Pfizer vaccine; This is a spontaneous report from a contactable physician reporting same events under the same suspect product for 10 total number patients. This is one of 10 reports. A patient of unspecified age and gender received two doses of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported ten patients had breakthrough infections. Local pharmacies in their area giving booster dose and the patients that had had the breakthrough infections had had two doses of the Pfizer vaccine on an unspecified date with outcome of unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported COVID infections based on the known safety profile.,Linked Report(s) : US-PFIZER INC-202101058062 same reporter/SD/AE, different patient

Other Meds:

Current Illness:

ID: 1655133
Sex: U
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: had the breakthrough infections had had two doses of the Pfizer vaccine; had the breakthrough infections had had two doses of the Pfizer vaccine; This is a spontaneous report from a contactable physician reporting same events under the same suspect product for 10 total number patients. This is one of 10 reports. A patient of unspecified age and gender received two doses of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported ten patients had breakthrough infections. Local pharmacies in their area giving booster dose and the patients that had had the breakthrough infections had had two doses of the Pfizer vaccine on an unspecified date with outcome of unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported COVID infections based on the known safety profile.,Linked Report(s) : US-PFIZER INC-202101058062 same reporter/SD/AE, different patient

Other Meds:

Current Illness:

ID: 1655134
Sex: U
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: had the breakthrough infections had had two doses of the Pfizer vaccine; had the breakthrough infections had had two doses of the Pfizer vaccine; This is a spontaneous report from a contactable physician reporting same events under the same suspect product for 10 total number patients. This is one of 10 reports. A patient of unspecified age and gender received two doses of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported ten patients had breakthrough infections. Local pharmacies in their area giving booster dose and the patients that had had the breakthrough infections had had two doses of the Pfizer vaccine on an unspecified date with outcome of unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported COVID infections based on the known safety profile.,Linked Report(s) : US-PFIZER INC-202101058062 same reporter/SD/AE, different patient

Other Meds:

Current Illness:

ID: 1655135
Sex: U
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: had the breakthrough infections had had two doses of the Pfizer vaccine; had the breakthrough infections had had two doses of the Pfizer vaccine; This is a spontaneous report from a contactable physician reporting same events under the same suspect product for 10 total number patients. This is one of 10 reports. A patient of unspecified age and gender received two doses of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported ten patients had breakthrough infections. Local pharmacies in their area giving booster dose and the patients that had had the breakthrough infections had had two doses of the Pfizer vaccine on an unspecified date with outcome of unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported COVID infections based on the known safety profile.,Linked Report(s) : US-PFIZER INC-202101058062 same reporter/SD/AE, different patient

Other Meds:

Current Illness:

Date Died: 08/24/2021

ID: 1655136
Sex: M
Age: 39
State: PA

Vax Date: 08/18/2021
Onset Date: 08/24/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: animal dander and certain plants

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: He was found dead in his home by friends who went looking for him after he didn't show up for work... possible suicide?

Other Meds: Seroquel / Ventolin inhaler

Current Illness: chronic asthma

ID: 1655137
Sex: F
Age: 31
State: NJ

Vax Date: 06/30/2021
Onset Date: 08/10/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: Peridone medicine

Symptom List: Unevaluable event

Symptoms: Getting boil on the arm where shot was taken. Arm getting sore and little painful. Headache and weakness felt

Other Meds: No

Current Illness: Tyroid, post pregnancy

ID: 1655138
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Subject lactating at time of vaccination on Aug 3. Baby, 7mos/M, had fever 38'C Aug 8-Aug 10. Baby recovered from fever. Infant was vaccinated with H. Influenza Jul 24 and had fever overnight.

Other Meds:

Current Illness:

ID: 1655139
Sex: M
Age: 31
State: VA

Vax Date: 08/26/2021
Onset Date: 08/27/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Fever developed after 7-10 hours from injection. Fever presisted for nearly 24 hours after first sign of symptoms. Slight nausea and weakness, chills, bedridden for the duration of the fever. Fever broke after 24 hours or so, weakness and chills persisted and gradually diminished over a further 24 hours. Full recovery at 72 hours from first symptoms.

Other Meds:

Current Illness:

ID: 1655140
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: experienced a fever after her first; headache; fatigue,; achiness; This is a spontaneous report from a contactable consumer or other non hcp. A 43-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration on an unspecified date (age at vaccination 43 years old) (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation.The patient medical history and concomitant medications were not reported. Caller also states that she experienced a fever after her first does but it was "not that bad" and also reports "I had all the other symptoms that are listed in terms of headache, achiness, fatigue, and blah blah blah." Caller is just concerned about the fever being this high and would like to know how long it is expected for this fever to last. Caller would like to know what medication would recommend to take to help with the fever, as far as Ibuprofen or Tylenol. Outcome of events was unknown. No follow-up attempts are possible; information about lot/batch number cannot been obtained

Other Meds:

Current Illness:

ID: 1655141
Sex: F
Age:
State: FL

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Fever; severe Body aches; head ache; unexplained odd discomfort in uterus and Fallopian tubes; High Blood pressure; This is a spontaneous report from a contactable consumer. A 73-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: 6199), via an unspecified route of administration, administered in Arm Left on 03Mar2021 13:30 (at the age of 73-year-old) as SINGLE DOSE for COVID-19 immunisation. Medical history included High BP from an unknown date and unknown if ongoing, gout from an unknown date and unknown if ongoing, Penicillin (Drug hypersensitivity) from an unknown date and unknown if ongoing. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection; Expiry Date: unknown, Lot number: 9269), via an unspecified route of administration on 10Feb2021 at 13:30 (at the age of 73-year-old) administered in Left arm as single dose for COVID-19 immunisation. It was reported that other vaccine not administered in four weeks. It was reported that Other medications was taken in two weeks. It was reported that it was unknown If patient had covid prior vaccination. Covid tested post vaccination was No. The patient experienced Fever, severe Body aches, headache and unexplained odd discomfort in uterus and Fallopian tubes and High Blood pressure on 04Mar2021 09:00. The patient did not received treatment for the event. The outcome of all event was Recovering. No follow up attempts are possible. Information about Lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1655142
Sex: F
Age:
State: IL

Vax Date: 03/13/2021
Onset Date: 03/01/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: dizziness/dizzy; abdominal pain; arm soreness to her right arm (injection side)/there is a red blotch (19Mar) on her arm on the injection site, sore arm, somewhat bleeding, pinkish; redness/pink area around injection site which is warm to the touch/there is a red blotch (19Mar) on her arm on the injection site, sore arm, somewhat bleeding, pinkish; there is a red blotch (19Mar) on her arm on the injection site, sore arm, somewhat bleeding, pinkish; I just felt a little prick; fungus allergy; little soreness in my muscle; This is a spontaneous report from a contactable consumer reported for herself. A 73-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EN6200; Expiration date was not reported), via an unspecified route of administration, administered in Arm Right on 13Mar2021 (at the age of 73-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included breast cancer from 2011 to an unknown date, brain aneurysm in 2015, stroke, fungus allergy from an unknown date and unknown if ongoing. Patient stated that 6 years ago in 2015 she had a brain aneurysm and had to go right to the hospital because she almost died and had 10 hours of brain surgery and then she was medically put into a coma so she could rest her brain. Her neurosurgeon was scared at the surgery because her heart rate and blood pressure went way down. He was afraid that she was going to die as she had a stroke, so he gave her a real light dose of blood pressure medicine and it brought everything back. Patient stated that was why she was taking blood pressure medicine. The patient's concomitant medications included blood pressure medicine (unspecified mediation). The patient previously took first dose of BNT162B2 on unspecified date for covid-19 immunisation. Patient received her second dose of the Pfizer Covid vaccine and it went so well that she did not even feel the needle go into her arm. Later that day she experienced dizziness and abdominal pain but felt that it might have been because she ate mushrooms and stated to have fungus allergy. She also reported arm soreness to her right arm (injection side) and redness/pink area around injection site which is warm to the touch. She took ibuprofen and wanted to know if this would have any effect on the vaccine. Referred caller to HCP for further discussion. Consumer stated of receiving second vaccine, hardly even felt anything on her arm, felt just a little prick and after she asked the person if she was already given that shot, she said yeah and said she didn't even feel that needle going into her arm but went to the grocery store on 17Mar2021 (the 17th of this month) and bought these 2 sandwiches that were kind of different, had mushrooms and patient made a mistake by eating one of them because she was allergic to fungus and she called that mushrooms and said she shouldn't have done that because anyway she didn't know if that had anything to do with her shot but got real dizzy and had pain in my abdomen but anyways this morning when she got up there was a red mark on her arm where the injection went, it was kind of lightening up, it wasn't a bright red it was kind of light red but it was going into a pink color and asked if it will go away by itself. Consumer was informed about Pfizer Medical information department and was provided with the number. Consumer stated she had a little soreness in her muscle, but it wasn't real sore but it was just sore by touching and that's because probably the needle went in there and that went away but then this morning when she got up there was a little red mark on my injection site but it was not swollen and so she took some Ibuprofen this week so she could get the soreness out of her muscle which it did take that away. Consumer stated, she was on blood pressure medicine (Unspecified mediation) also, asked if maybe that would have been a something wrong there, she did not tell that girl that she had blood pressure medicine that she was taking blood pressure medicine but that would not have affected her blood pressure medicine and asked if it would have. Treatment included none. Patient was not sure about her body weight. When asked about lab test, consumer stated no. She knew they take blood from her to check her kidneys, have had that done a couple of weeks ago and stated that wouldn't be any important for it. She got dizzy then it went away, took some Ibuprofen. This morning, there was a red blotch (19Mar) on her arm on the injection site, sore arm, somewhat bleeding, pinkish. Therapeutic measures were taken as a result of dizziness, arm soreness to her right arm (injection side)/there is a red blotch (19mar) on her arm on the injection site, sore arm, somewhat bleeding, pinkish. Clinical outcome of events was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1655143
Sex: M
Age:
State: VA

Vax Date: 04/26/2021
Onset Date: 04/27/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Nausea; Chills; Feelings of being "rundown"; Headache; Increased body temperature; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the right arm on 26Apr2021 at 14:45(at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 11:00, roughly 20 hours after the first vaccine, the patient experienced feelings of being rundown, headache and increased body temperature. Later in the night, roughly 30 hours after the vaccine, the patient experienced a sense of nausea, chills and still had an intense headache at the time of reporting. Therapeutic measures were not taken as a result of these events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event feelings of being "rundown", headache, increased body temperature, nausea and chills was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1655144
Sex: M
Age:
State: KY

Vax Date: 04/27/2021
Onset Date: 04/28/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Injection-site redness; Injection-site soreness; Injection-site swelling; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm right on 27Apr2021 at 14:15 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included obesity. Concomitant medications included loratadine (CLARITIN) and bismuth subsalicylate (PEPTO BISMOL) for unknown indication from an unknown date. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm right on 06Apr2021 at 14:15 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 08:30, the patient experienced injection-site redness, injection-site soreness and injection-site swelling. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event injection-site redness, injection-site soreness and injection-site swelling was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CLARITIN [LORATADINE]; PEPTO BISMOL [BISMUTH SUBSALICYLATE]

Current Illness:

ID: 1655145
Sex: M
Age:
State: KS

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Fine red itchy rash over all of upper torso; Fine red itchy rash over all of upper torso; Body aches; Arm sore; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 16Apr2021 at 10:45 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lisinopril/hydrochlorothiazide (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN) and vitamin C (MANUFACTURER UNKNOWN); all from an unknown date for an unknown indication and unknown if ongoing. On 17Apr2021, the patient experienced arm sore. On 18Apr2021, the patient experienced body aches. On 19Apr2021 at 00:00, the patient experienced a fine red itchy rash over all of upper torso. On 24Apr2021, the patient saw nurse practitioner due to rash increasing. The patient took off work for one week. The patient reported that had been taking zinc from pharmacy but 1 week ago switched to different brand and stopped it all together till this rash was gone. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of adverse events and included treatment with fexofenadine (ALLEGRA) in "am", diphenhydramine (BENADRYL), oatmeal baths, and triamcinolone (MANUFACTURER UNKNOWN) ointment. The clinical outcome of the events arm sore, body aches and fine red itchy rash over all of upper torso were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL/HCTZ; ZINC; VITAMIN C [ASCORBIC ACID]

Current Illness:

ID: 1655146
Sex: M
Age:
State: IL

Vax Date: 04/26/2021
Onset Date: 04/26/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Headache; Muscle pain; Joint pain; Chills; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 26Apr2021 at 07:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On 26Apr2021 at 07:00, the patient experienced headache, muscle pain, joint pain, and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, muscle pain, joint pain, and chills were recovered on an unknown date in Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is excepted.

Other Meds:

Current Illness:

ID: 1655147
Sex: F
Age:
State: OH

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Headache; Injection site pain; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533) via an unspecified route of administration in the right arm on 06Apr2021 at 15:15 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. The medical history were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On 06Apr2021, the patient experienced headache, injection site pain and fatigue. Therapeutic measures were not taken as a result of the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, injection site pain and fatigue were recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1655148
Sex: M
Age:
State: WA

Vax Date: 03/23/2021
Onset Date: 04/02/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20201111; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: "Approximately 1 week after, I woke up in the middle of the night and was incredibly aware that I could finally take a deep breath again. Additionally I noticed that my brain fog I had been living with had mostly cleared up."; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: "EN608") via an unspecified route of administration in the right arm on 23Mar2021 at 14:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to pollen and grass. On 11Nov2020, the patient underwent nasal swab test and the result was negative. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. On 02Apr2021 at 03:00, the patient had a positive effect to report and wanted to give a feedback of the experience of receding the vaccine because the patient thought it was truly a miracle. The patient understood that he was a "COVID long hauler". This term was given to the patient by his physician whom he consulted for shortness of breath and fatigue. He had a strange cold at the very beginning of the pandemic. At the time he was not wearing a mask. It was possible that got sick with the corona virus and had shortness of breath and poor mental clarity or brain fog since. After receiving the first shot of the vaccine, approximately one week after, he woke up at the middle of the night and was incredibly aware that could finally took a deep breath again after going through the majority of the last year not being able to take a deep breath. This was noticeable because the year before he was practicing cross fit and an amazing shape. Additionally the patient noticed that the brain fog had been lived with had mostly cleared up. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event "approximately 1 week after, he woke up in the middle of the night and was incredibly aware that he could finally take a deep breath again. Additionally he noticed that his brain fog he had been living with had mostly cleared up" was unknown at this time of report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0164) via an unspecified route of administration in the right arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1655149
Sex: F
Age:
State: WA

Vax Date: 03/30/2021
Onset Date: 04/05/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210421; Test Name: Mouth swab; Test Result: Negative

Allergies:

Symptom List: Tremor

Symptoms: Dry mouth; Rash on back and lower front stomach area. Small oblong slightly raised, itchy.; Rash on back and lower front stomach area. Small oblong slightly raised, itchy.; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 30Mar2021 at 12:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration on 21Apr2021 at 12:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included citalopram hydrobromide (CELEXA) and thyroid (ARMOUR THYROID); both from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced rash on back and lower front stomach area, small oblong slightly raised, itchy and dry mouth. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 21Apr2021, the patient underwent mouth swab and the result was negative. The clinical outcome of the events rash on back and lower front stomach area, small oblong slightly raised, itchy and dry mouth was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CELEXA [CITALOPRAM HYDROBROMIDE]; ARMOUR THYROID

Current Illness:

ID: 1655150
Sex: F
Age:
State: CA

Vax Date: 01/13/2021
Onset Date: 03/13/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210313; Test Name: Body temperature; Result Unstructured Data: Test Result:102 degree

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: 102 degree fever; Fatigue; Sever body aches; This is a spontaneous report from a contactable other healthcare professional, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL1283) via intramuscular route of administration in the left arm on 13Jan2021 at 15:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), montelukast sodium (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN), vitamin k nos (VITAMIN K), rivaroxaban (XARELTO), simvastatin, ezetimibe (BIROW) and tiotropium bromide monohydrate (SPIRIVA) for unknown indication from an unknown date. The patient previously received aspirin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EK5730) via intramuscular route of administration in the left arm on 11Dec2020 at 15:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Mar2021 at 18:00, the patient experienced 102-degree fever (Unspecified units), fatigue and sever body aches for 2 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of 102-degree fever, fatigue and sever body aches for 2 days were recovered on unspecified date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ALLEGRA; MONTELUKAST SODIUM; VITAMIN D NOS; VITAMIN K [VITAMIN K NOS]; XARELTO; BIROW; SPIRIVA

Current Illness:

ID: 1655151
Sex: M
Age:
State: IN

Vax Date: 03/21/2021
Onset Date: 03/01/2021
Rec V Date: 08/30/2021
Hospital: Y

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data: Test Name: Weight; Result Unstructured Data: Test Result:lost like 27 pounds; Comments: Started losing weight; have lost like 27 pounds

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: It feels like something's eating inside of my body/I feel it in my back around my center spine much of the time.; Started losing weight; have lost like 27 pounds; Coughing; I am getting kind of weak; Feels like something is stuck in my throat like I have to spit it; Sneezing; i have a hernia as a result from all the coughing; No appetite; no sex drive; This is a spontaneous report from a contactable consumer (Patient). A 64-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number, Expiry date was not reported), (at the age of 64-year-old) via an unspecified route of administration on 21Mar2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medication were not reported. Historical vaccine includes bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number, Expiry date was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization and experienced lost over 50 lbs in less than a month. On Mar2021, patient experienced it feels like something's eating inside of my body/ I feel it in my back around my center spine much of the time, started losing weight; have lost like 27 pounds, coughing, I am getting kind of weak, feels like something is stuck in my throat like I have to spit it, sneezing, I have a hernia as a result from all the coughing, no appetite, no sex drive. The events caused hospitalization for peritonitis, weight loss, coughing, weakness and pharyngitis. The patient underwent lab test includes weight lost like 27 pounds on an unspecified date. The clinical course reported as follows Consumer stated, "I took the vaccine (Unspecified Medication) a month ago, I think last month, the first shot. I started losing weight I have lost like 27 pounds and I started losing weight. That was the first shot, the second shot I had taken on 24th of last month, I start sneezing and coughing and It feels like something's eating inside of my body and I am losing my weight and stuff and I am getting kind of weak." Upon Follow-up (16Aug2021), the clinical course reported as follows on 29Aug2021 schedule for diagnostic and lab tests I have a hernia as a result of all the coughing that I was doing after the 2nd vaccination approximately 21Mar2021. I'm still coughing periodically, and the pathogen/stuff is still in my body, I feel it in my back around my center spine much of the time. I have no appetite or/and any sex drive. I was fine until I took the Pfizer vaccine. The patient did not received treatment for It feels like something's eating inside of my body/I feel it in my back around my center spine much of the time. Whereas patient received treatment for events Feels like something is stuck in my throat like I have to spit it, I am getting kind of weak, Coughing and Started losing weight; have lost like 27 pounds. The outcome of event It feels like something's eating inside of my body/I feel it in my back around my center spine much of the time and started losing weight; have lost like 27 pounds, coughing, I am getting kind of weak, feels like something is stuck in my throat like I have to spit it the outcome was not recovered. The outcome of event sneezing, I have a hernia as a result from all the coughing, no appetite, no sex drive the outcome was unknown. Follow-up (16Aug2021): The initial case was missing the following minimum criteria: suspect product is not reported or specified. Upon receipt of follow-up information on (16Aug2021), this case now contains all required information to be considered valid. This is a follow up spontaneous report from a contactable consumer. This 64-year-old male consumer (patient) reported in response to Non-HCP letter sent via follow-up letter which included that: New events "Hernia", "Appetite absent" and "Lack of libido" was coded and other clinical information added. Information about lot/batch number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1655152
Sex: M
Age:
State: NY

Vax Date: 03/31/2021
Onset Date: 04/11/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: sense of smell changed, It's best described as a burnt scent when around fried foods (deep and saute), toothpaste, and mouthwash.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8734) via an unspecified route of administration in the left arm on 31Mar2021 at 15:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. The medical history included ARVC (arrhythmogenic right ventricular cardiomyopathy), COVID-19 and penicillin allergy. Prior to the vaccination, the patient was diagnosed with COVID-19.The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. On 11Apr2021, about 11 days after the first dose of the vaccine, the patient experienced sense of smell changed. It was best described as a burnt scent when around fried foods (deep and saute), toothpaste and mouthwash. Therapeutic measures were not taken as a result of the reported event. The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sense of smell changed, it was best described as burned scent when around fried foods (deep and saute),toothpaste and mouthwash was unknown at the time of this report. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0170) via an unspecified route of administration in the left arm on 28Apr2021 at 14:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1655153
Sex: F
Age:
State: TX

Vax Date: 04/20/2021
Onset Date: 04/29/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Lymph node on my left side of neck near collarbone is sore and swollen.; Lymph node on my left side of neck near collarbone, is sore and swollen.; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 20Apr2021 at 15:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included citalopram hydrobromide (CELEXA), estrogens conjugated (PREMARIN) and ascorbic acid, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate (ONE-A-DAY) for adults, all taken for unspecified indications from unknown dates. The patient previously took erythromycin (MANUFACTURER UNKNOWN) and azithromycin (ZITHROMAX) and experienced drug allergy. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 13:00, the patient noticed that the lymph node on his left side of neck near the collarbone was sore and swollen. The patient did not seek any treatment, since research into possible side effects noted to swollen lymph nodes on the side where the vaccine was given. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event lymph node on left side of neck near collarbone was sore and swollen was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CELEXA [CITALOPRAM HYDROBROMIDE]; PREMARIN; ONE-A-DAY [ASCORBIC ACID;CYANOCOBALAMIN;ERGOCALCIFEROL;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL

Current Illness:

ID: 1655154
Sex: F
Age:
State: OK

Vax Date: 04/29/2021
Onset Date: 04/30/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Arm pain; Upset stomach; Nausea; Body aches; Fever; Insomnia; Shaking; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Apr2021 at 13:00(at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 08Apr2021 at 13:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccination. On 30Apr2021 at 01:00 the patient experienced arm pain, upset stomach, nausea, body aches, fever, insomnia and shaking. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm pain, upset stomach, nausea, body aches, fever, insomnia and shaking were unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1655155
Sex: F
Age:
State: MA

Vax Date: 04/15/2021
Onset Date: 04/18/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Skin rash, similar to those of chickenpox for vaccinated people, rashes started around neck area, then arms, waist, legs; Itchy; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 15Apr2021 at 14:45 (at an age of 62-years-old) as single dose for COVID-19 immunisation. The medical history of the patient included high blood pressure, acid reflux and allergy to penicillin and bee sting. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within 4 weeks prior to COVID vaccine. The patient received other medications (unspecified) within 2 weeks of vaccination. On 18Apr2021, two days after the second vaccination, the patient got skin rash (similar to those of chickenpox for vaccinated people). They still stay there after two weeks, but became less itchy. The rashes started around neck area, then arms, waist and legs. Therapeutic measures were taken as a result of the events with allergy relief over the counter medication(unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of skin rash, similar to those of chickenpox for vaccinated people, rashes started around neck area, then arms, waist, legs and itchy were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1655156
Sex: F
Age:
State: NJ

Vax Date: 04/28/2021
Onset Date: 04/29/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Low grade fever; Body ache/ pains; Headache; Eyes became swollen and very sore to touch; Eyes became swollen and very sore to touch; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8727) via an unspecified route of administration in the left arm on 28Apr2021 at 10:45 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to mollusks and possibly latex (could not use latex gloves as the skin would react with rash). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 0153) via an unspecified route of administration in the left arm on 10Apr2021 at 13:45 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. On 29Apr2021 at 14:00 (about 27 hours after the second dose), the patient experienced low grade fever, body ache, pains, headache, eyes became swollen and were very sore to the touch. The patient was breathing fine. At the time of reporting, 45 hours after the second dose, eyes were still swollen. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with over-the-counter (OTC) diphenhydramine hydrochloride (BENADRYL). The clinical outcome of the events low grade fever, body ache/ pains, headache, eyes became swollen and very sore to touch were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1655157
Sex: F
Age:
State: MI

Vax Date: 04/28/2021
Onset Date: 04/30/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: I have dermal fillers under my eyes and after the second dose my under eyes are swollen 2 days later.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 28Apr2021 at 16:15 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included derma fillers under the eye (Derma filler injection). Concomitant medications were not reported. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 07Apr2021 at 15:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had dermal fillers under the eyes and after the second dose under eyes were swollen 2 days later on 30Apr2021 at 08:00. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event eye swollen which included treatment with lisinopril (MANUFACTURER UNKNOWN) 10 mg. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event under eyes were swollen was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1655158
Sex: F
Age:
State: TX

Vax Date: 04/13/2021
Onset Date: 04/01/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Swelling in bilateral legs; Erythema Nodosum; This is a spontaneous report from a contactable healthcare professional. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via intramuscular route of administration on 13Apr2021 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other concomitant medications in two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via intramuscular route of administration on 23Mar2021 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 the patient experienced swelling in bilateral legs that transformed into erythema nodosum over two weeks, on an unknown date in Apr2021. The reported events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of adverse events and included treatment with unspecified NSAIDS (MANUFACTURER UNKNOWN). The clinical outcome of the event swelling in bilateral legs and erythema nodosum was recovering at the time of this report. No follow-up attempts are needed. No further information is expected

Other Meds:

Current Illness:

ID: 1655159
Sex: M
Age:
State: PA

Vax Date: 04/13/2021
Onset Date: 04/16/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Vomiting; Vertigo; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW01J1) via an unspecified route of administration in the left arm on 13Apr2021 at 10:15 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriasis and sulfonamide allergy (Sulfa). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ustekinumab (STELARA) for unknown indication, on an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 23Mar2021 at 10:15 (at the age of 57-yeasr-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 23:30 the patient experienced vomiting and vertigo. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events and included treatment with Antivert. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vomiting and vertigo was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: STELARA

Current Illness:

ID: 1655160
Sex: F
Age:
State: WA

Vax Date: 02/01/2021
Onset Date: 03/04/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210216; Test Name: NAVICA; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Vomiting

Symptoms: Multiple menses per month; Excessive bleeding; Anemia; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Feb2021 at 15:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccination. Concomitant medications included citalopram (MANUFACTURER UNKNOWN) and lansoprazole (MANUFACTURER UNKNOWN) for unknown indication from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Jan2021 at 15:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 04Mar2021 at 13:00, the patient experienced multiple menses per month, excessive bleeding and anemia diagnosis (Dx). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 16Feb2021, the patient underwent COVID test (navica test) via nasal swab and the result was negative. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events multiple menses per month, excessive bleeding and anemia were resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: CITALOPRAM; LANSOPRAZOLE

Current Illness:

ID: 1655161
Sex: F
Age:
State: FL

Vax Date: 04/28/2021
Onset Date: 04/29/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Right arm lymphadenopathy; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the right arm on 28Apr2021 at 11:30 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 07Apr2021 at 12:45 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 16:00, the patient experienced right arm lymphadenopathy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event lymphadenopathy was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1655162
Sex: F
Age:
State:

Vax Date: 04/28/2021
Onset Date: 04/01/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: not feeling well; tired; This is a spontaneous report from a non-contactable consumer. A female patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 28Apr2021, as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was unknown if the patient received any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Apr2021, the patient was not feeling well and tired. The clinical outcome of the event not feeling well and tired was unknown at the time of reporting. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected

Other Meds:

Current Illness:

ID: 1655163
Sex: F
Age:
State:

Vax Date: 04/29/2021
Onset Date: 04/29/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210429; Test Name: Body temperature; Result Unstructured Data: Test Result:Fever of 102

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Shaking; Can not move right arm over head; Body aches; Chills; Headache; Fever of 102; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the right arm on 29Apr2021 at 10:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 21:00, the patient experienced fever of 102 (unspecified units), body aches, chills, shaking uncontrollably, headache, cannot move right arm over her head. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever of 102 (unspecified units), body aches, chills, shaking uncontrollably, headache, cannot move right arm over her head were not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1655164
Sex: F
Age:
State: IL

Vax Date: 04/26/2021
Onset Date: 04/27/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: leg pain, particularly in left leg; warmth in leg; tingling in leg; headache; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0165) via an unspecified route of administration in the left arm on 26Apr2021 at 08:15 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and sumatriptan (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0151) via an unspecified route of administration in the left arm on 05Apr2021 at 08:15 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. On 27Apr2021 the patient experienced leg pain, particularly in left leg, warmth, tingling in leg and headache. No Therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events leg pain, warmth and tingling in leg and headache were recovered with sequelae on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN; SUMATRIPTAN

Current Illness:

ID: 1655165
Sex: M
Age:
State: TX

Vax Date: 04/20/2021
Onset Date: 04/26/2021
Rec V Date: 08/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Lost all my taste and smell; Lost all my taste and smell; now everything taste like metal or rotten; was tired for 4 days; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 20Apr2021 at 13:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant past medical history. The patient did not have any known allergies to food medications or other products. The patient did take any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021, the patient lost all his taste and smell. He had a super great sense of smell and taste, now everything tasted like metal or rotten, hard to describe. He was tired for 4 days, the lack of smell and taste was strange to him as he felt he had a strong sense of smell. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lost all taste and smell, everything taste like metal or rotten and tired for 4 days were not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am